ADX-629 Therapy for Sjogren-Larsson Syndrome

Clinical trial NCT05443685 · COMPLETED

Trial details

NCT number: NCT05443685
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sjogren-Larsson Syndrome

Start date: 2023-01-02
Primary completion: 2026-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.